BSX logo Boston Scientific Corporation +
Boston Scientific Corporation
+

Boston Scientific Corporation (BSX) Business News

Track Boston Scientific Corporation in real time with a live news feed covering Boston Scientific Corporation stock news, official press releases, company announcements, and an archive of historical Boston Scientific Corporation news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
10:30 AM | Friday | Jul 10, 2026 Zacks Investment Research

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

News Thumbnail
10:30 AM | Friday | Jul 10, 2026 Zacks Investment Research

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

News Thumbnail
2:15 AM | Thursday | Jul 9, 2026 The Motley Fool

Billionaire Steve Cohen Sold Amazon and Nvidia but Loaded Up on This Beaten-Down Stock

News Thumbnail
11:59 AM | Monday | Jul 6, 2026 Seeking Alpha

Boston Scientific: The Time Has Come To Catch This Falling Knife

News Thumbnail
7:02 PM | Tuesday | Jun 30, 2026 Zacks Investment Research

Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note

News Thumbnail
1:18 PM | Thursday | Jun 25, 2026 Seeking Alpha

Boston Scientific's Fall From Penthouse To Doghouse Creates A Value Opportunity

News Thumbnail
7:01 PM | Wednesday | Jun 24, 2026 Zacks Investment Research

Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note

News Thumbnail
10:30 AM | Tuesday | Jun 23, 2026 Zacks Investment Research

Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?

News Thumbnail
7:01 PM | Wednesday | Jun 17, 2026 Zacks Investment Research

Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note

News Thumbnail
12:15 AM | Saturday | Jun 13, 2026 The Motley Fool

Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months

News Thumbnail
11:49 AM | Friday | Jun 12, 2026 Seeking Alpha

Boston Scientific: The Market Is Pricing A Broken Compounder-We See A Reset One

News Thumbnail

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

Zacks Investment Research

10:30 AM | Friday | Jul 10, 2026

news photo
Loading...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Read full article redirect
10:30 AM | Friday | Jul 10, 2026

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

Zacks Investment Research

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Read full article arrow
News Thumbnail
10:30 AM | Friday | Jul 10, 2026

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

Zacks Investment Research

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Read full article arrow
News Thumbnail
2:15 AM | Thursday | Jul 9, 2026

Billionaire Steve Cohen Sold Amazon and Nvidia but Loaded Up on This Beaten-Down Stock

The Motley Fool

Amazon and Nvidia have been caught up in the AI trade, but have flatlined so far in 2026. Steve Cohen's Point72 Asset Management sold Amazon and Nvidia in the first quarter.

Read full article arrow
News Thumbnail
11:59 AM | Monday | Jul 6, 2026

Boston Scientific: The Time Has Come To Catch This Falling Knife

Seeking Alpha

Relative to its all-time high of $109.50 reached in September 2025, Boston Scientific Corporation's share price has declined by almost 60% to trade at around $45.00 per share. To put my money where my mouth is, I purchased my last shares on June 30th at an average price of $42.83.
My overall purchase price now stands at $45.52. As part of its Q1-26 earnings, Boston Scientific announced a significant outlook revision, reducing its organic growth guidance for fiscal 2026 to a range between 6.5% and 8.0%.

Read full article arrow
News Thumbnail
7:02 PM | Tuesday | Jun 30, 2026

Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note

Zacks Investment Research

In the most recent trading session, Boston Scientific (BSX) closed at $42.68, indicating a -1.84% shift from the previous trading day.

Read full article arrow
News Thumbnail
1:18 PM | Thursday | Jun 25, 2026

Boston Scientific's Fall From Penthouse To Doghouse Creates A Value Opportunity

Seeking Alpha

Boston Scientific has suffered a 50% share price decline amid decelerating growth and competitive threats, but fundamentals-based valuation now appears attractive. Growth in key segments like electrophysiology and Watchman has slowed due to increased competition, reimbursement cuts, and less impressive clinical trial data. Management now guides to sub-10% revenue growth (6.5%-8% for the year), but I still expect 7.5% annualized growth over five years and improving margins.

Read full article arrow
News Thumbnail
7:01 PM | Wednesday | Jun 24, 2026

Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks Investment Research

In the most recent trading session, Boston Scientific (BSX) closed at $44.46, indicating a -2.5% shift from the previous trading day.

Read full article arrow
News Thumbnail
10:30 AM | Tuesday | Jun 23, 2026

Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?

Zacks Investment Research

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Read full article arrow
News Thumbnail
7:01 PM | Wednesday | Jun 17, 2026

Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks Investment Research

Boston Scientific (BSX) closed the most recent trading day at $44.95, moving 4.2% from the previous trading session.

Read full article arrow
News Thumbnail
12:15 AM | Saturday | Jun 13, 2026

Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months

The Motley Fool

Boston Scientific's shares have fallen over 50% year to date as the medtech company continues to walk back full-year 2026 guidance. Sell-side analysts remain relatively upbeat on the stock.

Read full article arrow
News Thumbnail
11:49 AM | Friday | Jun 12, 2026

Boston Scientific: The Market Is Pricing A Broken Compounder-We See A Reset One

Seeking Alpha

Boston Scientific has experienced a ~53% collapse over twelve months, driven by guidance cuts, WATCHMAN deceleration, EP share loss, and a mixed CHAMPION-AF readout. FY26 guidance was cut to 6.5-8.0% organic growth and $3.34-$3.
41 EPS, with management tempering long-term 10%+ growth expectations. BSX trades at a significant discount to peers (12.6x FY27E P/E), despite maintaining a robust ~8% revenue and ~10-11% EPS growth profile.

Read full article arrow
News Thumbnail